Effects of low - dose aspirin on clinic and ambulatory blood pressure in <font color="red">treated_2</font> <font color="red">hypertensive_2</font> <font color="red">patients_2</font> <font color="red">._2</font> Collaborative Group of the Primary Prevention Project ( PPP)--Hypertension study . 
<br>
<br> Nonsteroidal antiinflammatory drugs may affect blood pressure ( BP ) control in <font color="red">hypertensive_2</font> <font color="red">patients_2</font> <font color="red">receiving_2</font> <font color="red">drug_2</font> <font color="red">treatment_2</font> <font color="red">,_2</font> but data on the effects of low - dose aspirin are scanty . This study assessed the effects of chronic treatment with low doses of aspirin ( 100 mg / day ) on clinic and ambulatory systolic ( SBP ) and diastolic ( DBP ) BP in <font color="red">hypertensives_2</font> <font color="red">on_2</font> <font color="red">chronic_2</font> <font color="red">,_2</font> <font color="red">stable_2</font> <font color="red">antihypertensive_2</font> <font color="red">therapy_2</font> <font color="red">._2</font> The study was conducted in the framework of the Primary Prevention Project ( PPP ) , a randomized , controlled factorial trial on the preventive effect of aspirin or vitamin E in people with one or more cardiovascular risk factors . <font color="red">Fifteen_1</font> <font color="red">Italian_1</font> <font color="red">hypertension_1</font> <font color="red">units_1</font> <font color="red">studied_1</font> <font color="red">142_2</font> <font color="red">hypertensive_2</font> <font color="red">patients_2</font> <font color="red">(_2</font> <font color="red">76_2</font> <font color="red">men_2</font> <font color="red">,_2</font> <font color="red">66_2</font> <font color="red">women_2</font> <font color="red">;_2</font> <font color="red">mean_2</font> <font color="red">age_2</font> <font color="red">59_2</font> <font color="red">+_2</font> <font color="red">/-_2</font> <font color="red">5.9_2</font> <font color="red">years_2</font> <font color="red">)_2</font> <font color="red">treated_2</font> <font color="red">with_2</font> <font color="red">different_2</font> <font color="red">antihypertensive_2</font> <font color="red">drugs_2</font> <font color="red">:_2</font> 71 patients were randomized to aspirin and 71 served as controls . All patients underwent a clinic BP evaluation with an automatic sphygmomanometer and a 24-h ambulatory BP monitoring , at baseline and after 3 months of aspirin treatment . At the end of the study the changes in clinic SBP and DBP were not statistically different in treated and untreated subjects . Ambulatory SBP and DBP after 3 months of aspirin treatment were similar to baseline : deltaSBP -0.5 mmHg ( 95% confidence intervals [ CI ] from -1.9 to + 2.9 mm Hg ) and deltaDBP -1.1 mm Hg ( 95% CI from -2.5 to + 0.3 mm Hg ) . The pattern was similar in the control group . No interaction was found between aspirin and the most used antihypertensive drug classes ( angiotensin converting enzyme inhibitors and calcium antagonists ) . Despite the relatively small sample size our results seem to exclude any significant influence of low - dose aspirin on BP control in <font color="red">hypertensives_1</font> <font color="red">under_1</font> <font color="red">treatment_1</font> <font color="red">._1</font>